Skip to main content
. 2014 Sep 9;6(9):3536–3571. doi: 10.3390/nu6093536

Table 2.

Urine volumes and fecal excretion in intact normoglycemic and db/db mice.

Groups Urine Volume (mL/24 h/Mouse): Days after Initial Treatment Fecal Excretion (g/24 h/Mouse): Days after Initial Treatment
28 63 83 28 63 83
Controls
Intact 1.53 ± 0.47 1.55 ± 0.23 1.54 ± 0.32 1.06 ± 0.32 1.12 ± 0.19 1.14 ± 0.17
db 9.91 ± 1.96 d 16.84 ± 2.25 a 17.78 ± 2.29 d 1.39 ± 0.22 d 1.40 ± 0.21 b 1.40 ± 0.17 a
Reference
Metformin 7.45 ± 1.85 df 13.16 ± 1.70 ab 13.69 ± 1.35 de 1.75 ± 0.27 de 1.77 ± 0.26 ab 1.75 ± 0.25 ab
GT 400 mg/kg 7.88 ± 1.32 d 13.83 ± 2.01 ab 14.39 ± 0.91 de 1.69 ± 0.17 df 1.71 ± 0.16 ab 1.66 ± 0.17 ab
fGT treated
400 mg/kg 5.74 ± 1.21 deg 7.39 ± 2.11 abc 7.65 ± 2.38 deg 2.04 ± 0.07 deg 2.18 ± 0.22 abc 2.13 ± 0.14 abc
200 mg/kg 5.86 ± 0.99 deg 8.80 ± 1.79 abc 9.19 ± 2.17 deg 1.97 ± 0.16 deh 2.01 ± 0.18 abc 1.93 ± 0.14 abc
100 mg/kg 7.08 ± 2.10 df 12.43 ± 2.96 ab 14.68 ± 1.34 de 1.75 ± 0.33 df 1.75 ± 0.24 ab 1.74 ± 0.25 ab

Values are expressed mean ± S.D. of eight mice. GT, Green tea aqueous lyophilized extracts; fGT, Aquilariae Lignum-fermented green tea aqueous lyophilized extracts; metformin was administrated at a dose level of 250 mg/kg; a p < 0.01 as compared with intact control by LSD test; b p < 0.01 as compared with db control by LSD test; c p < 0.01 as compared with GT 400 mg/kg by LSD test; d p < 0.01 as compared with intact control by MW test; e p < 0.01; f p < 0.05 as compared with db control by MW test; g p < 0.01; h p < 0.05 as compared with GT 400 mg/kg by MW test.